Clinical Trial

HWS116 Monotherapy in Patients With Advanced Solid Tumors

Name: HWS116 Monotherapy in Patients With Advanced Solid Tumors — clinical trial record (NCT07413328)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase I open-label study that will evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of HWS116 monotherapy in patients with advanced solid tumors.

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-29

Trial Details

NCT Number	NCT07413328
Lead Sponsor	Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
Conditions	Advanced Solid Tumors
Enrollment	56 participants
Start Date	2026-04-07
Primary Completion	2027-08-31 (estimated)
Study Completion	2028-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-04-28